Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer.
It is used in patients in which it has spread to other parts of the
body, who have abnormal epidermal growth factor receptor (EGFR) genes,
and who have not had previous treatment for cancer.
Geftinat Tablet side effects
Nausea, Rash, Vomiting, Weakness, Loss of appetite, Dry skin, Diarrhoea, Stomatitis (Inflammation of the mouth).
How to use Geftinat Tablet
this medicine in the dose and duration as advised by your doctor.
Swallow it as a whole. Do not chew, crush or break it. Geftinat 250mg
Tablet may be taken with or without food, but it is better to take it at
a fixed time.
How Geftinat Tablet works
250mg Tablet is an anti-cancer medication. It works by blocking the
action of the abnormal protein that signals cancer cells to multiply.
This helps to stop or slow the spread of cancer cells.
Geftinat Tablet related warnings
Special precautions for Geftinat Tablet
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Geftinat 250mg Tablet is unsafe to use during pregnancy. There
is positive evidence of human fetal risk, but the benefits from use in
pregnant women may be acceptable despite the risk, for example in
life-threatening situations. Please consult your doctor.
Geftinat 250mg Tablet is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
Do not drive unless you are feeling well. Geftinat 250mg Tablet may make you feel weak. This may affect your driving ability.
250mg Tablet should be used with caution in patients with severe kidney
disease. Dose adjustment of Geftinat 250mg Tablet may be needed. Please
consult your doctor.
250mg Tablet is probably safe to use in patients with liver disease.
Limited data available suggests that dose adjustment of Geftinat 250mg
Tablet may not be needed in these patients. Please consult your doctor.